Literature DB >> 6740479

Interhemispheric approach through the lamina terminalis to tumors of the anterior part of the third ventricle.

J Suzuki, R Katakura, T Mori.   

Abstract

Operative approaches to tumors of the third ventricle, mainly the bifrontal approach through the lamina terminalis, are discussed. The latter approach has several advantages. First, the main arteries can be exposed and the operative field is sufficiently wide to render the operative procedure safe. Second, cortical incision or excision is unnecessary. By cutting the lamina terminalis, which is usually thin and expanded as a result of hydrocephalus, even a large tumor can be removed. In addition, lethal complications are avoided, because this approach has less possibility of damage to the lateral wall of the third ventricle. Seventeen cases of tumor in the third ventricle underwent operation via this approach. The operative technique for the bifrontal approach through the lamina terminalis and three representative cases are reported. This approach can be applied not only to tumors, but to arteriovenous malformations or giant aneurysms adjacent to the third ventricle.

Entities:  

Mesh:

Year:  1984        PMID: 6740479     DOI: 10.1016/0090-3019(84)90044-2

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  10 in total

Review 1.  Anatomic study of the lamina terminalis: neurosurgical relevance in approaching lesions within and around the third ventricle.

Authors:  R Shane Tubbs; Ha Son Nguyen; Marios Loukas; Aaron A Cohen-Gadol
Journal:  Childs Nerv Syst       Date:  2012-06-08       Impact factor: 1.475

2.  Resection of tumors of the third ventricle involving the hypothalamus: effects on body mass index using a dedicated surgical approach.

Authors:  Pietro Mortini; Filippo Gagliardi; Michele Bailo; Nicola Boari; Antonella Castellano; Andrea Falini; Marco Losa
Journal:  Endocrine       Date:  2016-09-29       Impact factor: 3.633

3.  [Application of the "five-line division method" in selecting surgical approach for spaceoccupying lesions in the saddle area and the adjacent areas].

Authors:  Chengwei Yu; Zhenhua Song; Chengyong Liu; Danian Wei
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

4.  Lamina terminalis approach for retrochiasmal craniopharyngiomas.

Authors:  S N Bhagwati; C E Deopujari; G D Parulekar
Journal:  Childs Nerv Syst       Date:  1990-12       Impact factor: 1.475

5.  Fronto-basal interhemispheric approach for craniopharyngiomas extending outside the suprasellar cistern.

Authors:  Reizo Shirane; Toshiaki Hayashi; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2005-07-21       Impact factor: 1.475

6.  Anterior callosal section is useful for the removal of large tumors invading the dorsal part of the anterior third ventricle: operative technique and results.

Authors:  Hideki Shiramizu; Tomokatsu Hori; Seigo Matsuo; Kaku Niimura; Haruko Yoshimoto; Atsushi Ishida; Keizoh Asakuno; Miki Yuzawa; Takashi Moriyama
Journal:  Neurosurg Rev       Date:  2013-04-09       Impact factor: 3.042

7.  Surgical treatment of anterior third ventricle tumours.

Authors:  A N Konovalov; S K Gorelyshev
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

8.  Outcome of endoscopy-assisted microscopic extended transsphenoidal surgery for suprasellar adult craniopharyngiomas.

Authors:  Hidetoshi Ikeda; Hiromi Gotoh; Kazuo Watanabe
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-20       Impact factor: 5.555

9.  Ganglioglioma in the third ventricle: report on two cases.

Authors:  Tadahisa Shono; Masahiko Tosaka; Kenichi Matsumoto; Sadao Onaka; Shinya Yamaguchi; Masahiro Mizoguchi; Toru Iwaki; Yoichi Nakazato; Tomio Sasaki
Journal:  Neurosurg Rev       Date:  2007-05-10       Impact factor: 2.800

10.  Predicting the necessity of anterior communicating artery division in the bifrontal basal interhemispheric approach.

Authors:  Shinichiro Teramoto; Helmut Bertalanffy
Journal:  Acta Neurochir (Wien)       Date:  2016-06-22       Impact factor: 2.216

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.